Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „tocilizumab“
Suchtreffer
Begriffe & Kennungen
Carvykti · 4.5 · Some patients in the clinical trials on CARVYKTI required tocilizumab, corticosteroids and anakinra for manage
Eintrag öffnenColumvi · 4.8 · Among the 22 patients who experienced Grade 2 CRS after Columvi, 16 (72.7%) received tocilizumab, 15 (68.2%)
Eintrag öffnenColumvi · 4.8 · Among the 25 patients who experienced Grade 2 CRS after Columvi, 22 (88.0%) received tocilizumab, 15 (60.0%)
Eintrag öffnenColumvi · 4.8 · Out of the 76 patients with any grade CRS, 28 patients (36.8%) were treated with tocilizumab, 39 patients (51.
Eintrag öffnenElrexfio · 4.8 · 13 Among patients who developed ICANS, 66.7% received corticosteroids, 33.3% received tocilizumab (or siltuxim
Eintrag öffnenLunsumio · 4.8 · Tocilizumab and/or corticosteroids were used to manage a CRS event in 12% of patients: 5.7% received tocilizum
Eintrag öffnenLunsumio · 4.8 · Tocilizumab and/or corticosteroids were used to manage a CRS event in 16% of patients: 6% received tocilizumab
Eintrag öffnenLynozyfic · 4.8 · In the clinical study, 19% of patients received tocilizumab and 11% received corticosteroids for the managemen
Eintrag öffnenRoActemra · 4.5 · Concomitant administration of a single dose of 10 mg/kg tocilizumab with 10-25 mg MTX once weekly had no clini
Eintrag öffnenRoActemra · 4.5 · Concomitant administration of a single dose of 10 mg/kg tocilizumab with 10-25 mg MTX once weekly had no clini
Eintrag öffnenRoActemra · 4.5 · Concomitant administration of a single dose of 10 mg/kg tocilizumab with 10-25 mg MTX once weekly had no clini
Eintrag öffnenRoActemra · 4.5 · Population pharmacokinetic analyses did not detect any effect of MTX, NSAIDs or corticosteroids on tocilizumab
Eintrag öffnenRoActemra · 4.5 · Population pharmacokinetic analyses did not detect any effect of MTX, NSAIDs or corticosteroids on tocilizumab
Eintrag öffnenRoActemra · 4.5 · When starting or stopping therapy with tocilizumab, patients taking medicinal products which are individually
Eintrag öffnenRoActemra · 4.5 · When starting or stopping therapy with tocilizumab, patients taking medicinal products which are individually
Eintrag öffnenRoActemra · 4.5 · When starting or stopping therapy with tocilizumab, patients taking medicinal products which are individually
Eintrag öffnenRoActemra · 4.8 · 14 Table 2. List of adverse reactions1 identified from the pooled safety-evaluable population from tocilizumab
Eintrag öffnenRoActemra · 4.8 · 18 Neutrophils During routine laboratory monitoring in the tocilizumab all exposure population, a decrease in
Eintrag öffnenRoActemra · 4.8 · 19 Immunogenicity All 112 patients were tested for anti-tocilizumab antibodies at baseline. Two patients devel
Eintrag öffnenRoActemra · 4.8 · 46 Table 1. List of adverse reactions occurring in patients treated with tocilizumab
Eintrag öffnen